Unveiling the Potential Drug Target and Biomarker for NDUFA3P3: NADH: Ubiquinone Oxidoreductase Subunit A3 Pseudogene 3

Target Name: NDUFA3P3

NCBI ID: G644482

NDUFA3P3

Other Name(s): NADH:ubiquinone oxidoreductase subunit A3 pseudogene 3 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 pseudogene 3

Unveiling the Potential Drug Target and Biomarker for NDUFA3P3: NADH: Ubiquinone Oxidoreductase Subunit A3 Pseudogene 3

Introduction

NADH: Ubiquinone Oxidoreductase (NADH:UR) is an essential enzyme involved in the final step of the electron transport chain in the cell. It catalyzes the conversion of NADH to NAD+, which is a crucial coenzyme for the production of ATP energy. NDUFA3P3 (NADH:ubiquinone oxidoreductase subunit A3 pseudogene 3) is a specific pseudogene associated with the NADH:UR enzyme. The function and potential clinical applications of NDUFA3P3 have been investigated extensively in the scientific literature. In this article, we will provide a comprehensive overview of NDUFA3P3, including its function, potential drug targets, and potential use as a biomarker.

Function of NDUFA3P3

NDUFA3P3 is a 17-kDa protein that is expressed in various tissues, including liver, muscle, and heart. It is a crucial component of the NADH:UR enzyme, which catalyzes the conversion of NADH to NAD+. NADH is a crucial coenzyme for the The production of ATP energy, and the production of NAD+ is essential for the regulation of various cellular processes, including energy metabolism, redox homeostasis, and signaling pathways.

Potential Drug Targets

NDUFA3P3 has been identified as a potential drug target due to its involvement in the NADH:UR enzyme. The inhibition of this enzyme has been shown to enhance the production of NAD+ and improve the function of NAD+ in various cellular systems. Several studies have suggested that Targeting NDUFA3P3 may be a promising strategy for the treatment of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

NDUFA3P3 has been shown to interact with several protein targets, including

Protein Name: NADH:ubiquinone Oxidoreductase Subunit A3 Pseudogene 3

The "NDUFA3P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFA3P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets